niflumic acid has been researched along with Nasopharyngeal Carcinoma in 1 studies
Niflumic Acid: An analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.
Nasopharyngeal Carcinoma: A carcinoma that originates in the EPITHELIUM of the NASOPHARYNX and includes four subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and PAPILLARY ADENOCARCINOMA. It is most prevalent in Southeast Asian populations and is associated with EPSTEIN-BARR VIRUS INFECTIONS. Somatic mutations associated with this cancer have been identified in NPCR, BAP1, UBAP1, ERBB2, ERBB3, MLL2, PIK3CA, KRAS, NRAS, and ARID1A genes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Niflumic acid (NFA) was known to inhibit cell proliferation or migration in several types of cancer." | 5.42 | Niflumic acid exhibits anti-tumor activity in nasopharyngeal carcinoma cells through affecting the expression of ERK1/2 and the activity of MMP2 and MMP9. ( Chen, C; Chen, H; Chen, L; He, Z; Huang, G; Huang, Z; Li, B; Li, H; Liao, D; Luo, S; Wan, Z; Wang, Z, 2015) |
| "Niflumic acid (NFA) was known to inhibit cell proliferation or migration in several types of cancer." | 1.42 | Niflumic acid exhibits anti-tumor activity in nasopharyngeal carcinoma cells through affecting the expression of ERK1/2 and the activity of MMP2 and MMP9. ( Chen, C; Chen, H; Chen, L; He, Z; Huang, G; Huang, Z; Li, B; Li, H; Liao, D; Luo, S; Wan, Z; Wang, Z, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Luo, S | 1 |
| Huang, G | 1 |
| Wang, Z | 1 |
| Wan, Z | 1 |
| Chen, H | 1 |
| Liao, D | 1 |
| Chen, C | 1 |
| Li, H | 1 |
| Li, B | 1 |
| Chen, L | 1 |
| Huang, Z | 1 |
| He, Z | 1 |
1 other study available for niflumic acid and Nasopharyngeal Carcinoma
| Article | Year |
|---|---|
Niflumic acid exhibits anti-tumor activity in nasopharyngeal carcinoma cells through affecting the expression of ERK1/2 and the activity of MMP2 and MMP9.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma; Cell Division; Cell Line, Tumor; Cell Movement; Cell Pr | 2015 |